Outpatient exercise training for chronic lung disease - for whom, how and why?

被引:0
|
作者
Gloeckl, Rainer [1 ]
Jarosch, Inga [1 ]
Koczulla, Andreas Rembert [1 ,2 ,3 ]
机构
[1] Schon Klin Berchtesgadener Land, Forschungsinst Pneumol Rehabil, Malterhoh 1, D-83471 Schonau, Germany
[2] Philipps Univ Marburg Standort Schonau, Deutsch Zentrum Lungenforsch DZL, Schon Klin Berchtesgadener Land, Schonau, Germany
[3] Paracelsus Med Privatuniv, Lehrkrankenhaus, Salzburg, Austria
关键词
Pneumologische Rehabilitation; COPD; Rehasport; pulmonary rehabilitation; training;
D O I
10.1055/a-2165-5788
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a legal entitlement to participate in outpatient exercise groups in accordance with the German Social Code (Book IX) which regulates and facilitates prescriptions for patients with chronic respiratory diseases. A medical examination with specific inclusion and exclusion criteria prior to admission to an exercise group ensures safe participation. Traditional outpatient exercise groups are conducted in face-to-face groups for 60 to 90 minutes, once a week, with structured warm-up, main and cool-down phases. In addition, since the coronavirus pandemic, the introduction of online exercise groups via videoconferencing has enabled flexible participation (even without a prescription). To date, more than 11,000 German patients have participated in online exercise groups since 2021.Scientific evidence confirms the significant benefits of regular exercise, such as improved physical performance and reduced breathlessness. The psychosocial benefits and the promotion of self-efficacy are additionally supported by the supervision of a specialized trainer. Regular exercise (e.g. in outpatient exercise groups) is an inexpensive and very effective form of therapy to improve the quality of life of people with chronic respiratory diseases.
引用
收藏
页码:1367 / 1371
页数:5
相关论文
共 50 条
  • [1] Exercise training in chronic heart failure: why, when and how
    Dubach, P
    Sixt, S
    Myers, J
    SWISS MEDICAL WEEKLY, 2001, 131 (35-36) : 510 - 514
  • [2] Pulmonary rehabilitation in chronic obstructive pulmonary disease: Androgenotherapy, why? For whom? How?
    Thibault, Ronan
    Samaras, Nikolaos
    Samaras, Dimitrios
    Chambellan, Arnaud
    Pichard, Claude
    NUTRITION CLINIQUE ET METABOLISME, 2016, 30 (01): : 74 - 82
  • [3] Assessment of comorbidity in lung cancer: How, why, and in whom?
    Gajra, Ajeet
    JOURNAL OF GERIATRIC ONCOLOGY, 2016, 7 (02) : 64 - 67
  • [4] EXERCISE AND TRAINING IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG-DISEASE
    COX, NJM
    VANHERWAARDEN, CLA
    FOLGERING, H
    BINKHORST, RA
    SPORTS MEDICINE, 1988, 6 (03) : 180 - 192
  • [5] EXERCISE TRAINING AS THERAPY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE
    BASS, H
    FORMAN, R
    HURST, PR
    KUSCH, M
    DISEASES OF THE CHEST, 1969, 56 (03): : 242 - &
  • [6] Outpatient commitment: What, why, and for whom
    Torrey, EF
    Zdanowicz, M
    PSYCHIATRIC SERVICES, 2001, 52 (03) : 337 - 341
  • [7] EXERCISE TRAINING IN TREATMENT OF CHRONIC OBSTRUCTIVE LUNG-DISEASE
    HODGKIN, JE
    WESTERN JOURNAL OF MEDICINE, 1975, 123 (01): : 46 - 46
  • [8] Exercise training in chronic heart failure: Why?
    Cohen-Solal A.
    Guiti C.
    Geyer C.
    Logeart D.
    Ennezat P.-V.
    Heart Failure Reviews, 1999, 3 (4) : 287 - 297
  • [9] Exercise Testing and Training in Chronic Lung Disease and Pulmonary Arterial Hypertension
    Arena, Ross
    PROGRESS IN CARDIOVASCULAR DISEASES, 2011, 53 (06) : 454 - 463
  • [10] Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?
    Berentsen, Sigbjorn
    Barcellini, Wilma
    D'Sa, Shirley
    Jilma, Bernd
    IMMUNOTHERAPY, 2022, 14 (15) : 1191 - 1204